000874656 001__ 874656
000874656 005__ 20210130004736.0
000874656 0247_ $$2doi$$a10.1016/j.clinph.2019.11.002
000874656 0247_ $$2ISSN$$a0921-884X
000874656 0247_ $$2ISSN$$a1388-2457
000874656 0247_ $$2ISSN$$a1872-8952
000874656 0247_ $$2Handle$$a2128/24589
000874656 0247_ $$2altmetric$$aaltmetric:73668738
000874656 0247_ $$2pmid$$apmid:31901449
000874656 0247_ $$2WOS$$aWOS:000507859400021
000874656 037__ $$aFZJ-2020-01572
000874656 082__ $$a610
000874656 1001_ $$0P:(DE-HGF)0$$aLefaucheur, Jean-Pascal$$b0$$eCorresponding author
000874656 245__ $$aEvidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018)
000874656 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2020
000874656 3367_ $$2DRIVER$$aarticle
000874656 3367_ $$2DataCite$$aOutput Types/Journal article
000874656 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1585041604_3401
000874656 3367_ $$2BibTeX$$aARTICLE
000874656 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000874656 3367_ $$00$$2EndNote$$aJournal Article
000874656 520__ $$aA group of European experts reappraised the guidelines on the therapeutic efficacy of repetitive transcranial magnetic stimulation (rTMS) previously published in 2014 [Lefaucheur et al., Clin Neurophysiol 2014;125:2150–206]. These updated recommendations take into account all rTMS publications, including data prior to 2014, as well as currently reviewed literature until the end of 2018. Level A evidence (definite efficacy) was reached for: high-frequency (HF) rTMS of the primary motor cortex (M1) contralateral to the painful side for neuropathic pain; HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC) using a figure-of-8 or a H1-coil for depression; low-frequency (LF) rTMS of contralesional M1 for hand motor recovery in the post-acute stage of stroke. Level B evidence (probable efficacy) was reached for: HF-rTMS of the left M1 or DLPFC for improving quality of life or pain, respectively, in fibromyalgia; HF-rTMS of bilateral M1 regions or the left DLPFC for improving motor impairment or depression, respectively, in Parkinson’s disease; HF-rTMS of ipsilesional M1 for promoting motor recovery at the post-acute stage of stroke; intermittent theta burst stimulation targeted to the leg motor cortex for lower limb spasticity in multiple sclerosis; HF-rTMS of the right DLPFC in posttraumatic stress disorder; LF-rTMS of the right inferior frontal gyrus in chronic post-stroke non-fluent aphasia; LF-rTMS of the right DLPFC in depression; and bihemispheric stimulation of the DLPFC combining right-sided LF-rTMS (or continuous theta burst stimulation) and left-sided HF-rTMS (or intermittent theta burst stimulation) in depression. Level A/B evidence is not reached concerning efficacy of rTMS in any other condition. The current recommendations are based on the differences reached in therapeutic efficacy of real vs. sham rTMS protocols, replicated in a sufficient number of independent studies. This does not mean that the benefit produced by rTMS inevitably reaches a level of clinical relevance.
000874656 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000874656 588__ $$aDataset connected to CrossRef
000874656 7001_ $$0P:(DE-HGF)0$$aAleman, André$$b1
000874656 7001_ $$0P:(DE-Juel1)131948$$aBaeken, Chris$$b2
000874656 7001_ $$0P:(DE-HGF)0$$aBenninger, David H.$$b3
000874656 7001_ $$0P:(DE-HGF)0$$aBrunelin, Jérôme$$b4
000874656 7001_ $$0P:(DE-HGF)0$$aDi Lazzaro, Vincenzo$$b5
000874656 7001_ $$0P:(DE-HGF)0$$aFilipović, Saša R.$$b6
000874656 7001_ $$0P:(DE-Juel1)161406$$aGrefkes, Christian$$b7
000874656 7001_ $$0P:(DE-HGF)0$$aHasan, Alkomiet$$b8
000874656 7001_ $$0P:(DE-HGF)0$$aHummel, Friedhelm C.$$b9
000874656 7001_ $$0P:(DE-HGF)0$$aJääskeläinen, Satu K.$$b10
000874656 7001_ $$0P:(DE-HGF)0$$aLangguth, Berthold$$b11
000874656 7001_ $$0P:(DE-HGF)0$$aLeocani, Letizia$$b12
000874656 7001_ $$0P:(DE-HGF)0$$aLondero, Alain$$b13
000874656 7001_ $$0P:(DE-HGF)0$$aNardone, Raffaele$$b14
000874656 7001_ $$0P:(DE-HGF)0$$aNguyen, Jean-Paul$$b15
000874656 7001_ $$0P:(DE-HGF)0$$aNyffeler, Thomas$$b16
000874656 7001_ $$0P:(DE-HGF)0$$aOliveira-Maia, Albino J.$$b17
000874656 7001_ $$0P:(DE-HGF)0$$aOliviero, Antonio$$b18
000874656 7001_ $$0P:(DE-HGF)0$$aPadberg, Frank$$b19
000874656 7001_ $$0P:(DE-HGF)0$$aPalm, Ulrich$$b20
000874656 7001_ $$0P:(DE-HGF)0$$aPaulus, Walter$$b21
000874656 7001_ $$0P:(DE-HGF)0$$aPoulet, Emmanuel$$b22
000874656 7001_ $$0P:(DE-HGF)0$$aQuartarone, Angelo$$b23
000874656 7001_ $$0P:(DE-HGF)0$$aRachid, Fady$$b24
000874656 7001_ $$0P:(DE-HGF)0$$aRektorová, Irena$$b25
000874656 7001_ $$0P:(DE-HGF)0$$aRossi, Simone$$b26
000874656 7001_ $$0P:(DE-HGF)0$$aSahlsten, Hanna$$b27
000874656 7001_ $$0P:(DE-HGF)0$$aSchecklmann, Martin$$b28
000874656 7001_ $$0P:(DE-HGF)0$$aSzekely, David$$b29
000874656 7001_ $$0P:(DE-HGF)0$$aZiemann, Ulf$$b30
000874656 773__ $$0PERI:(DE-600)1499934-1$$a10.1016/j.clinph.2019.11.002$$gVol. 131, no. 2, p. 474 - 528$$n2$$p474 - 528$$tClinical neurophysiology$$v131$$x1388-2457$$y2020
000874656 8564_ $$uhttps://juser.fz-juelich.de/record/874656/files/Lefaucheur_2020_Clin%20Neurophysiol_Evidence-based%20guidelines%20on%20the%20therapeutic%20use%20of%20repetitive%20transcranial%20magnetic%20stimulation%20%28TMS_%20An%20update.pdf$$yOpenAccess
000874656 8564_ $$uhttps://juser.fz-juelich.de/record/874656/files/Lefaucheur_2020_Clin%20Neurophysiol_Evidence-based%20guidelines%20on%20the%20therapeutic%20use%20of%20repetitive%20transcranial%20magnetic%20stimulation%20%28TMS_%20An%20update.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000874656 909CO $$ooai:juser.fz-juelich.de:874656$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000874656 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131948$$aForschungszentrum Jülich$$b2$$kFZJ
000874656 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)161406$$aForschungszentrum Jülich$$b7$$kFZJ
000874656 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000874656 9141_ $$y2020
000874656 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000874656 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000874656 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000874656 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
000874656 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCLIN NEUROPHYSIOL : 2017
000874656 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000874656 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000874656 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000874656 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000874656 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000874656 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000874656 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000874656 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000874656 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000874656 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000874656 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000874656 920__ $$lyes
000874656 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000874656 980__ $$ajournal
000874656 980__ $$aVDB
000874656 980__ $$aUNRESTRICTED
000874656 980__ $$aI:(DE-Juel1)INM-3-20090406
000874656 9801_ $$aFullTexts